Recently, the list of pre-awarded projects of the 23rd China Patent Award was announced. The invention patent declared by Lunan Pharmaceutical Group Co., Ltd. “A Traditional Chinese Medicine Composition for Treating Infantile Cough and Its Preparation Method (Patent No.: ZL03100185) .8)” won the China Patent Silver Award.
China Patent Award, co-sponsored by the State Intellectual Property Office of China and the World Intellectual Property Organization, is the only invention in China that specifically grants patents Create government sector awards that give awards, which are recognized by the United Nations World Intellectual Property Organization (WIPO).
Children’s Xiaoji cough-relieving products (Ningbao Nimble®) are the exclusive Chinese medicine varieties of Lunan Pharmaceutical Group. It is composed of 10 medicinal materials, such as Radix, Platycodon grandiflorum, Forsythia, and Cicada. It clears heat and eliminates lung, eliminates accumulation and relieves cough, treats spleen as the foundation, treats lung as the standard, treats both lung and spleen, eliminates food accumulation, and stops cough. , won the first prize of Shandong Province Science and Technology Progress Award, the first prize of Shandong Province Patent Award, the first prize of Linyi City Patent Award, and the first prize of Shandong Provincial Food and Drug Administration’s Pharmaceutical Science and Technology Progress Award.
High-quality traditional Chinese medicine products are inseparable from the support of a first-class high-end platform. In order to further enhance the high-end development of the traditional Chinese medicine industry, Lunan Pharmaceutical Group has established a domestic first-class State Key Laboratory of Traditional Chinese Medicine Pharmaceutical Common Technology (referred to as The establishment of the Guozhong Office realizes the seamless connection between enterprises and universities, creates a five-point integrated development model of “production-learning-research-application-service”, and promotes the innovation and development of the traditional Chinese medicine pharmaceutical industry.
Up to now, Lunan Pharmaceutical Group has applied for more than 740 Chinese medicine patents, of which more than 350 are authorized. It has laid a solid foundation for the company’s future Chinese medicine research and development and marketing.
Qilu Evening News·Qilu One Point Correspondent Liu Qingdong